For the quarter ending 2026-04-04, IRIX has $28,274K in assets. $23,542K in debts. $4,595K in cash and cash equivalents.
| Balance Sheets | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 |
|---|---|---|---|---|
| Cash and cash equivalents | 4,595 | 6,028 | 5,573 | 6,778 |
| Accounts receivable, net | 6,844 | 7,613 | 7,132 | 7,137 |
| Receivable from related party | 1,572 | 1,932 | 2,398 | 2,893 |
| Inventories | 9,325 | 7,877 | 7,301 | 8,435 |
| Prepaid expenses and other current assets | 2,248 | 1,802 | 1,662 | 1,625 |
| Total current assets | 24,584 | 25,252 | 24,066 | 26,868 |
| Property and equipment, net | 139 | 58 | 23 | 40 |
| Gross carrying value | 2,539 | 2,539 | 2,539 | - |
| Accumulated amortization | 1,635 | 1,555 | 1,475 | - |
| Goodwill | - | - | - | 1,000 |
| Intangible assets, net | 904 | 984 | 1,064 | 1,144 |
| Goodwill | 965 | 965 | 965 | 965 |
| Operating lease right-of-use assets, net | 496 | 768 | 1,039 | 1,295 |
| Other long-term assets | 1,186 | 1,124 | 1,196 | 1,273 |
| Total assets | 28,274 | 29,151 | 28,353 | 31,585 |
| Accounts payable | 5,753 | 5,385 | 4,409 | 5,314 |
| Payable to related party | 301 | 117 | 213 | 435 |
| Accrued compensation | 1,718 | 2,340 | 1,932 | 1,861 |
| Convertible note payable, current | - | 0 | 0 | 0 |
| Accrued expenses | 692 | 608 | 592 | 584 |
| Other current liabilities | 1,900 | 1,899 | 2,010 | 2,101 |
| Deferred revenue, current | 2,040 | 2,160 | 2,208 | 2,269 |
| Operating lease liabilities, current | 424 | 699 | 1,028 | 1,145 |
| Total current liabilities | 12,828 | 13,208 | 12,392 | 13,709 |
| Deferred revenue | 6,422 | 6,801 | 7,208 | 7,587 |
| Operating lease liabilities | 87 | 98 | 52 | 248 |
| Convertible note payable | 3,765 | 3,735 | 3,705 | 3,675 |
| Other long-term liabilities | 440 | 387 | 315 | 307 |
| Total liabilities | 23,542 | 24,229 | 23,672 | 25,526 |
| Preferred stock, 0.01 par value authorized 2,000,000 shares issued and outstanding 600,000 shares of series b convertible preferred stock as of both april 4, 2026 and january 3, 2026 (liquidation preference of 6.0 million as of both april 4, 2026 and january 3, 2026) | 6,000 | 6,000 | 6,000 | 6,000 |
| Common stock, 0.01 par value authorized 63,500,000 shares issued and outstanding 17,395,350 shares as of april 4, 2026 and 17,306,521 as of january 3, 2026 | 174 | 174 | 174 | 174 |
| Additional paid-in capital | 91,538 | 91,208 | 90,782 | 90,587 |
| Accumulated other comprehensive loss | -10 | -14 | -13 | -13 |
| Accumulated deficit | -92,970 | -92,446 | -92,262 | -90,689 |
| Total stockholders equity | 4,732 | 4,922 | 4,681 | 6,059 |
| Total liabilities, convertible preferred stock, and stockholders' equity | 28,274 | 29,151 | 28,353 | 31,585 |
IRIDEX CORP (IRIX)
IRIDEX CORP (IRIX)